VP of SciClone Pharmaceuticals was just granted 50,000 options

Raymond Anthony Low, VP of SciClone Pharmaceuticals, just received 50,000 options from the company. The strike price of the options received was $4.75, and these expire on October 15, 2023. Low now owns at least 50,000 options on the company.

Some additional info was provided as follows:

Granted under the Issuer's 2005 Equity Incentive Plan. 25% of such shares vest one year from the date of grant and 2.0833% vests each month thereafter, provided that Reporting Person continues to be employed by the Issuer.

The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here. SciClone Pha rmaceuticals next reports earnings on November 04, 2014.

To receive a free e-mail notification whenever SciClone Pharmaceuticals makes a similar move, sign up!

Other recent filings from the company include the following:

SciClone Pharmaceuticals just filed a General Statement of acquisition of beneficial ownership - Jan. 22, 2015
Wilson W. Cheung Jane Green Chief Financial Officer Investors/Media 650.358.3434 650.358.1447 Wcheung@Sciclone.Com Jgreen@Sciclone.Com - Jan. 6, 2015

   Auto Refresh